Simply Solventless Concentrates Ltd. Stock
Stocks
HASH
CA82888A1021
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Toronto S.E.
15/10/2026
|
5-day change | 1st Jan Change | ||
| 0.0550 CAD | 0.00% |
|
0.00% | -60.71% |
| Market Cap | 6.35M 4.47M 3.99M 3.71M 3.38M 424M 6.47M 44.59M 17.45M 221M 16.79M 16.44M 708M | P/E 2024 |
-10x | P/E 2025 | -0.58x |
|---|---|---|---|---|---|
| Enterprise Value | 23.36M 16.45M 14.68M 13.65M 12.41M 1.56B 23.78M 164M 64.14M 813M 61.74M 60.43M 2.6B | EV / Sales 2024 |
6.8x | EV / Sales 2025 | 1.14x |
| Free-Float |
80.98% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| HASH | End-of-day quote | |
OTC Markets
| SSLCF | Delayed | |
|
Deutsche Boerse AG
| Y3I | Delayed |
| Current month | +22.22% | ||
| 1 month | +22.22% | ||
| 6 months | +57.14% | ||
| Current year | -60.71% |
| 1 week | 0.05 |  | 0.06 |
| 1 month | 0.04 | | 0.06 |
| Current year | 0.04 | | 0.19 |
| 1 year | 0.04 | | 0.26 |
| 3 years | 0.04 | | 0.84 |
| 5 years | 0.04 | | 0.84 |
| 10 years | 0.04 | | 0.84 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/2/26 | Buy | Director | 5,500 | 0.0057% | ||
| 10/2/26 | Buy | Director | 5,000 | 0.0052% | ||
| 10/2/26 | Buy | Director | 9,500 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -76.60% | -78.85% | 4.45M | |
| +3.55% | +5.29% | +54.07% | +105.45% | 1,077B | |
| -0.25% | -2.00% | +32.71% | +61.48% | 612B | |
| +0.59% | +4.44% | +23.69% | +91.54% | 501B | |
| -1.48% | +1.68% | +71.42% | +39.59% | 364B | |
| +2.37% | +5.47% | +32.67% | +48.87% | 353B | |
| +2.64% | +4.90% | +21.01% | +43.85% | 278B | |
| +3.24% | +4.25% | -0.31% | +15.71% | 251B | |
| +1.86% | +5.07% | +47.70% | +52.77% | 230B | |
| +2.49% | +7.16% | +32.82% | +102.67% | 190B | |
| Average | +1.50% | +2.77% | +23.92% | +48.31% | 385.65B | |
| Weighted average by Cap. | +1.74% | +1.58% | +39.06% | +71.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.68M 9.64M 8.6M 7.99M 7.27M 913M 13.93M 96.02M 37.57M 476M 36.16M 35.39M 1.52B | 29.06M 20.47M 18.27M 16.98M 15.45M 1.94B 29.58M 204M 79.81M 1.01B 76.81M 75.18M 3.24B |
| Net income | -5.19M -3.66M -3.27M -3.04M -2.76M -347M -5.29M -36.46M -14.27M -181M -13.73M -13.44M -579M | -27.33M -19.25M -17.18M -15.97M -14.53M -1.82B -27.82M -192M -75.05M -951M -72.24M -70.71M -3.04B |
| Net Debt | 9.1M 6.41M 5.72M 5.32M 4.84M 607M 9.26M 63.87M 24.99M 317M 24.05M 23.54M 1.01B | 17M 11.98M 10.69M 9.94M 9.04M 1.13B 17.31M 119M 46.7M 592M 44.94M 43.99M 1.89B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | CA$0.0550 | 0.00% | 6,000 |
| 14/10/26 | CA$0.0550 | 0.00% | 19,000 |
| 13/10/26 | CA$0.0550 | 0.00% | 238,810 |
| 07/10/26 | CA$0.0550 | +10.00% | 722,648 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HASH Stock
Select your edition
All financial news and data tailored to specific country editions
